Form D · Pharmaceuticals
Medsyn Biopharma LLC
Northville, MI · CIK 0001966428
Offering snapshot reported Nov 4, 2025 · SEC filing
- Reported sold
- $11.5M Offering amount: $11.5M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 20, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 4, 2025 | Initial | $11,499,999 | No comparison | 16 | SEC filing |
| Aug 15, 2024 | Initial | $5,000,000 | No comparison | 5 | SEC filing |
| Mar 3, 2023 | Initial | $3,090,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-562995
Source: Form D, filed Nov 4, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mel Sorensen John | Director, Executive |
| Martin Matthew | Executive |
| Gilbert S. Omenn | Director |
| John Mel Sorensen | Director, Executive |
| Shaomeng Wang | Director |
| Brian Wood | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
120 W Main St. Ste 300
Northville, MI, 48167-1584
Phone: (610) 725-1500
Northville, MI, 48167-1584
Phone: (610) 725-1500